RTW Biotech Opportunities (LON:RTW - Get Free Report) dropped 3.5% on Wednesday . The company traded as low as GBX 1.10 ($0.01) and last traded at GBX 1.10 ($0.01). Approximately 265,996 shares changed hands during mid-day trading, an increase of 20% from the average daily volume of 221,595 shares. The stock had previously closed at GBX 1.14 ($0.02).
RTW Biotech Opportunities Price Performance
The firm has a market capitalization of £386.30 million, a PE ratio of 2.74 and a beta of 0.60. The company has a 50-day moving average price of GBX 1.26 and a 200-day moving average price of GBX 1.39.
About RTW Biotech Opportunities
(
Get Free Report)
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Articles
Before you consider RTW Biotech Opportunities, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RTW Biotech Opportunities wasn't on the list.
While RTW Biotech Opportunities currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
